Huberman M - Search Results

1

Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: a double-blind study as adjunctive therapy to levodopa.

Rabey JM, Sagi I, Huberman M, Melamed E, Korczyn A, Giladi N, Inzelberg R, Djaldetti R, Klein C, Berecz G; Rasagiline Study Group. Rabey JM, et al. Among authors: huberman m. Clin Neuropharmacol. 2000 Nov-Dec;23(6):324-30. doi: 10.1097/00002826-200011000-00005. Clin Neuropharmacol. 2000. PMID: 11575866 Clinical Trial.

2

High prevalence of malignant melanoma in Israeli patients with Parkinson's disease.

Inzelberg R, Rabey JM, Melamed E, Djaldetti R, Reches A, Badarny S, Hassin-Baer S, Cohen O, Trau H, Aharon-Peretz J, Milo R, Schwartz M, Huberman M, Gilead L, Barchana M, Liphshiz I, Fitzer-Attas C, Giladi N. Inzelberg R, et al. Among authors: huberman m. J Neural Transm (Vienna). 2011 Aug;118(8):1199-207. doi: 10.1007/s00702-011-0580-2. Epub 2011 Feb 5. J Neural Transm (Vienna). 2011. PMID: 21298300

3

Electrogastrography in patients with Parkinson's disease.

Naftali T, Gadoth N, Huberman M, Novis B. Naftali T, et al. Among authors: huberman m. Can J Neurol Sci. 2005 Feb;32(1):82-6. doi: 10.1017/s0317167100016929. Can J Neurol Sci. 2005. PMID: 15825551

4

Integration of motor imagery and physical practice in group treatment applied to subjects with Parkinson's disease.

Tamir R, Dickstein R, Huberman M. Tamir R, et al. Among authors: huberman m. Neurorehabil Neural Repair. 2007 Jan-Feb;21(1):68-75. doi: 10.1177/1545968306292608. Neurorehabil Neural Repair. 2007. PMID: 17172556 Clinical Trial.

5

Cerebral venous thrombosis and chronic active hepatitis as part of the antiphospholipid syndrome.

Kesler A, Pomeranz IS, Huberman M, Novis B, Kott E. Kesler A, et al. Among authors: huberman m. Postgrad Med J. 1996 Nov;72(853):690-2. doi: 10.1136/pgmj.72.853.690. Postgrad Med J. 1996. PMID: 8944216 Free PMC article.

6

Decreased IL-3 production by peripheral blood mononuclear cells in patients with multiple sclerosis.

Huberman M, Shalit F, Roth-Deri I, Gutman B, Kott E, Sredni B. Huberman M, et al. J Neurol Sci. 1993 Aug;118(1):79-82. doi: 10.1016/0022-510x(93)90249-x. J Neurol Sci. 1993. PMID: 8229053

7

Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage.

Huberman M, Shalit F, Roth-Deri I, Gutman B, Brodie C, Kott E, Sredni B. Huberman M, et al. J Neuroimmunol. 1994 Jul;52(2):147-52. doi: 10.1016/0165-5728(94)90108-2. J Neuroimmunol. 1994. PMID: 8034754

8

Myasthenia gravis: rarity of gallstone formation.

Kott E, Kerber G, Huberman M, Kott I. Kott E, et al. Among authors: huberman m. Neurology. 1994 Jan;44(1):154-6. doi: 10.1212/wnl.44.1.154. Neurology. 1994. PMID: 8290052

9

IL-2 and IL-6 secretion in dementia: correlation with type and severity of disease.

Huberman M, Sredni B, Stern L, Kott E, Shalit F. Huberman M, et al. J Neurol Sci. 1995 Jun;130(2):161-4. doi: 10.1016/0022-510x(95)00016-u. J Neurol Sci. 1995. PMID: 8586980 Clinical Trial.

10

Fibrosing alveolitis associated with primary antiphospholipid syndrome.

Savin H, Huberman M, Kott E, Lishner M, Kitai Y, Kidron D, Zissin R, Ravid M. Savin H, et al. Among authors: huberman m. Br J Rheumatol. 1994 Oct;33(10):977-80. doi: 10.1093/rheumatology/33.10.977. Br J Rheumatol. 1994. PMID: 7921762

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters